Neothera has raised ₹9 crore in its latest pre-seed funding round. Blume Ventures led the investment round in the early stage. Fellow participants in the funding round included a variety of institutional investors and special venture funds, including The Barbershop Fund, led by the Founder of Bombay Shaving Company, Shantanu Deshpande. Institutional investors joined in the round, including Consumer Collective and Veltis Capital, reinforcing the financial backing of Neothera’s science-focused approach in skincare.

Vision and leadership

Apart from the institutional VC funds and investment groups, a few well-known angel investors were also part of the pre-seed funding, hailing from the world of consumer brands and technology companies. Individual investors comprise some top-notch corporate executives, including Arjun Purkayastha, who is a Senior Vice President and Managing Director of Reckitt, and Malika Sadani, founder of the brand The Moms Co.

The investor base also includes the Founder of Classplus, Mukul Rastogi, the Founder of Samosa Party, Diksha Pandey, and several experienced names in the industry who have voiced their confidence in Neothera’s niche healthcare solution.

Neothera is founded and led by its Founder, Dr. Radhika Agarwal. Having previously acted as a Consumer-Tech investor with Blume Ventures, Radhika Agarwal is deeply familiar with the investment landscape and is bringing that expertise to her startup. Her entrepreneurial and professional success was marked by her recently becoming a Honouree of Forbes 30 Under 30 Asia 2023. This foundation in consumer technology and venture capital gives her the strategic understanding required to scale a science-driven consumer health business in a competitive and crowded marketplace.

She works with Neothera to create a foundational goal that seeks to treat the underlying cause of chronic skin issues instead of superficial short-term solutions. The company’s core belief that skin problems are multifaceted and complex and can’t be solved with one product alone is the first principle. The company is aimed at disrupting the familiar skincare industry by providing more substantial, long-term results for those with ongoing skin problems instead of short-lived symptomatic relief.

Scientific methodology and capital allocation

In order to achieve all these health benefits, Neothera has adopted a multi-pronged approach by launching customized acne care programmes. Neothera takes advantage of different areas of study and comes up with a holistic care ecosystem.

These ingredients coexist with every bit of expert professional advice and clinically proven formulations. Through this distinctive blending, the startup can deliver more than topical products typical for the industry, delivering a structural care offering that tackles internal and external conditions impacting skin well-being.

The product is now commercially available, following a comprehensive and rigorous developmental period of almost 20 months. In these 20 months, the company focused its efforts on comprehensive research, formulation development, intensive testing, and extensive beta trials. 

The essential foundation work was carried out in collaboration with a multidisciplinary panel of doctors and nutritionists, as well as with professional formulators. The startup made sure to have all its initial product portfolio built from scratch to ensure total control over quality and scientific integrity. Neothera has already prepared for its early adopters by carefully testing and developing its comprehensive treatment plans based on the feedback of those who have already used it for treatment, before releasing them to the broader public markets.

The fresh fund allocation of ₹9 crore will be utilized in various strategic growth areas to build a strong market footprint. The proceeds will be dedicated to further enhancing Neothera’s technology capabilities that drive the backend of its diagnostics and care tracking programs. A substantial proportion of the investment will be used for strengthening its existing product base and for continued research and development programs to ensure the clinical efficacy and validation of its formulations.

Beyond technology and product development, the investment in the pre-seed stage will also be used to build the startup’s human resources by augmenting its internal clinical and scientific workforce. This expansion will guarantee that their care programs will always include expert guidance. This capital will support scaling customer acquisition efforts across India, enabling the startup to expand its reach into the Indian consumer base actively engaged in seeking sustainable, science-supported solutions to chronic skin health issues.

Conclusion

With a funding round success of ₹9 crore, Neothera is highlighting the investors’ fascination with deep health knowledge when it comes to beauty products. The startup’s expertise in 20 months of research, its own product formulation, and a multidisciplinary care plan will enable it to compete in a traditional skin care market. Under the leadership of Blume Ventures and the Barbershop Fund and several seasoned consumer tech angel investors, Neothera has the capital and experience needed to advance its technology, grow its clinical teams, and provide sustained acne care to consumers across India.